FLORENCE: a randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk

Spina, M. ; Nagy, Z. ; Ribera, J.M. ; Federico, M. ; Aurer, I. ; Jordan, K. ; Borsaru, G. ; Pristupa, A.S. ; Bosi, A. ; Grosicki, S. ; Glushko, N.L. ; Ristic, D. ; Jakucs, J. ; Montesinos, P. ; Mayer, J. ; Rego, E.M. ; Baldini, S. ; Scartoni, S. ; Capriati, A. ; Maggi, C.A. ; Simonelli, C.

Annals of oncology, 2015-10, Vol.26 (10), p.2155-2161 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível